[1]颜丙萍,刘 莉.颅脑外伤患者血清S100-β、和肽素水平变化及其与预后相关性研究[J].陕西医学杂志,2025,54(2):217-221.[doi:DOI:10.3969/j.issn.1000-7377.2025.02.015]
　YAN Bingping,LIU Li.Changes of serum S100-β and copeptin levels in patients with traumatic brain injury and their correlation with prognosis[J].,2025,54(2):217-221.[doi:DOI:10.3969/j.issn.1000-7377.2025.02.015]
点击复制

颅脑外伤患者血清S100-β、和肽素水平变化及其与预后相关性研究
分享到：

《陕西医学杂志》[ISSN:1000-7377/CN:61-1281/TN]

卷:
54
期数:
2025年2期
页码:
217-221
栏目:
临床研究
出版日期:
2025-02-05

文章信息/Info

Title:
Changes of serum S100-β and copeptin levels in patients with traumatic brain injury and their correlation with prognosis
作者:
颜丙萍; 刘 莉
(山东第一医科大学附属省立医院神经外科,山东 济南 250021)
Author(s):
YAN Bingping; LIU Li
(Department of Neurosurgery,Provincial Hospital Affiliated to Shandong First Medical University,Jinan 250021,China)
关键词:
颅脑外伤;  S100-β;  和肽素;  预后;  影响因素;  预测价值
Keywords:
Traumatic brain injury;  S100-β;  Copeptin;  Prognosis;  Influencing factors;  Predictive value
分类号:
R 651.15
DOI:
DOI:10.3969/j.issn.1000-7377.2025.02.015
文献标志码:
A
摘要:
目的:探讨颅脑外伤患者血清中枢神经特异蛋白(S100-β)、和肽素水平变化及其与预后的相关性。方法:选取颅脑外伤患者152例为颅脑外伤组,另选取同期体检健康者为63例对照组。比较两组血清S100-β、和肽素水平。采用格拉斯哥昏迷量表(GCS)评分评估患者病情严重程度,并将患者分为轻度组(50例)、中度组(59例)和重度组(43例),比较三组血清S100-β、和肽素水平。根据出院时预后情况将患者分为预后不良组(45例)和预后良好组(107例),比例两组临床资料。采用多因素Logistic回归分析颅脑外伤患者预后不良的影响因素。绘制受试者工作特征(ROC)曲线分析血清S100-β、和肽素对颅脑外伤患者预后不良的预测价值。结果:与对照组比较,颅脑外伤组血清S100-β、和肽素水平升高(均P<0.05)。轻度、中度、重度组患者血清S100-β、和肽素水平依次升高(均P<0.05)。与预后良好组比较,预后不良组受伤至救治时间≥6 h、马歇尔CT分级≥Ⅳ级、中线移位≥5 mm患者占比、急性生理学和慢性健康状况评价Ⅱ(APACHEⅡ)评分以及血清S100-β、和肽素水平升高,GCS评分降低(均P<0.05)。受伤至救治时间、马歇尔CT分级、中线移位、GCS评分、APACHEⅡ评分、血清S100-β、血清和肽素是颅脑外伤患者预后不良的独立影响因素(均P<0.05)。血清S100-β、和肽素联合预测颅脑外伤患者预后不良的曲线下面积(AUC)大于两者单独预测的AUC(均P<0.05)。结论:颅脑外伤患者血清S100-β、和肽素水平升高,是患者预后不良的影响因素,两者联合对于预后预测具有较高的价值。
Abstract:
Objective:To investigate the changes in serum levels of S100-β and copeptin in patients with traumatic brain injury and their correlation with prognosis.Methods:A total of 152 patients with traumatic brain injury were selected as the TBI group,and 63 healthy individuals from the same period physical examination were selected as the control group.Serum levels of S100-β and copeptin were compared between the two groups.The Glasgow Coma Scale(GCS)score was used to assess the severity of the patients' conditions,and patients were divided into mild(50 cases),moderate(59 cases)and severe(43 cases)groups to compare serum levels of S100-β and copeptin.Patients were further divided into poor prognosis group(45 cases)and good prognosis group(107 cases)based on their discharge outcomes,and the clinical data of the two groups were compared.Multifactorial logistic regression analysis was used to identify the influencing factors of poor prognosis in patients with traumatic brain injury.Receiver operating characteristic(ROC)curves were plotted to analyze the predictive value of serum S100-β and copeptin for poor prognosis in patients with traumatic brain injury.Results:Compared with the control group,the serum levels of S100-β and copeptin were increased in the TBI group(all P<0.05).The serum levels of S100-β and copeptin increased progressively from mild to moderate to severe groups(all P<0.05).Compared with the good prognosis group,the poor prognosis group had a longer time from injury to treatment(≥6 hours),higher Marshall CT grade(≥Ⅳ),greater midline shift(≥5 mm),higher APACHE Ⅱscore,and increased serum levels of S100-β and copeptin,while the GCS score was decreased(all P<0.05). Time to treatment,Marshall CT grade,midline shift,GCS score,APACHE Ⅱ score,serum S100-β and serum copeptin were independent influencing factors for poor prognosis in patients with traumatic brain injury(all P<0.05).The combined prediction of serum S100-β and copeptin for poor prognosis in patients with traumatic brain injury had a larger area under the curve(AUC)than either alone(all P<0.05).Conclusion:Increased serum levels of S100-β and copeptin in patients with traumatic brain injury are factors affecting poor prognosis,and their combined use has a high predictive value for prognosis.

参考文献/References:

[1] PROCÈS A,GABRIELE S.Deciphering the mechanobiology of microglia in traumatic brain injury with advanced microsystems[J].Neural Regen Res,2024,20(8):2304-2306.
[2] YOU X,NIU L,FU J,et al.Bidirectional regulation of the brain-gut-microbiota axis following traumatic brain injury[J].Neural Regen Res,2024,20(8):2153-2168.
[3] 李俊梅,米丹丽,李建英,等.神经节苷脂联合脑苷肌肽治疗创伤性颅脑损伤临床价值研究[J].陕西医学杂志,2024,53(8):1092-1096.
[4] 杨菊荣,王菊霞,刘艳,等.神经功能指标联合磷酸酶和张力蛋白同源物检测对重型颅脑损伤患者预后的预测价值[J].陕西医学杂志,2023,52(11):1593-1597.
[5] 聂晓改,彭传梅,张云芳,等.S100-β、IL-6、hs-CRP联合检测明显提高急性创伤性颅脑损伤诊断的灵敏性[J].实用医学杂志,2024,40(11):1580-1585.
[6] 汪潇,孟令文.颅脑外伤术后血清S100-β及脑脊液P38蛋白与认知功能的关系[J].中国医药导报,2023,20(7):97-100,109.
[7] 余雄武,李世富,丁志勇,等.血清和肽素联合Marshall CT分级对婴幼儿颅脑创伤预后的评估价值[J].中国医药导报,2022,19(18):90-93.
[8] 冯爱平,王文,杜陈.重症颅脑损伤术后血清和肽素、胶质纤维酸性蛋白水平与患者预后的关系[J].实用医院临床杂志,2022,19(1):132-135.
[9] 王成立,周林裕,梁哲勇.基于TSP-1和APACHEⅡ评分构建老年重型颅脑损伤患者院内死亡的预测模型[J].中国实用神经疾病杂志,2024,27(7):816-820.
[10] 赵峰,沈子渊,杨翠,等.LIPS评分联合APACHEⅡ评分和氧合指数预测ARDS发生模型的建立和验证[J].中华危重病急救医学,2022,34(10):1048-1054.
[11] SEPLOVICH G,BOUCHI Y,DE-RIVERO-VACCARI J P,et al.Inflammasome links traumatic brain injury,chronic traumatic encephalopathy,and Alzheimer's disease[J].Neural Regen Res,2024,20(6):1644-1664.
[12] ABYADEH M,GUPTA V,YOU Y,et al.Visualizing traumatic brain injury:Ocular clues for diagnosis and assessment[J].Neural Regen Res.2024,20(5):1399-1400.
[13] 陈月阳,王景景,任党利,等.泛素结合酶E2L3通过NF-κB/COX2通路调节颅脑创伤后小胶质细胞介导神经炎症的实验研究[J].中华神经外科杂志,2024,40(9):952-958.
[14] 聂晓改,张云芳,庄杉杉,等.急性创伤性颅脑损伤入院即刻检验相关指标分析[J].昆明医科大学学报,2024,45(9):122-128.
[15] 李晓菲.血清神经元特异性烯醇化酶、S100-β蛋白、脑红蛋白对早产儿脑白质损伤的诊断价值[J].河北医药,2022,44(6):930-932.
[16] 王梦.丙泊酚-瑞芬太尼-七氟醚静吸复合维持麻醉在颅脑肿瘤手术中的麻醉效果及对心功能血清S100-β蛋白浓度的影响[J].山西医药杂志,2021,50(20):2908-2911.
[17] 王英,廖英.血清S100B、IL-1β、IL-6水平与颅脑损伤患者损伤程度和预后的相关性研究[J].川北医学院学报,2021,36(10):1352-1354,1394.
[18] 徐亚辉,才丽娜,贺大权,等.活血复健汤治疗脑卒中疗效及对患者神经功能与血清相关指标的影响[J].陕西中医,2020,41(11):1615-1618.
[19] 吴日暖,吴用,杨丽霞,等.血清Copeptin、ficolin-3及NSE水平评估儿童创伤性脑损伤伤情严重程度的价值[J].创伤外科杂志,2020,22(9):684-688.
[20] 吴玉成,李云升,桑运锋,等.急性冠脉综合征患者经皮冠状动脉介入治疗前后血清和肽素及可溶性生长刺激表达基因2水平变化及其预测价值研究[J].实用心脑肺血管病杂志,2019,27(11):35-39.
[21] 祁金敏,李宗喜,全凯.亚低温辅治重型颅脑损伤及对血清和肽素、高迁移率族蛋白B1、微管相关蛋白tau的影响[J].实用医院临床杂志,2021,18(3):118-121.
[22] 李祥全,姜莹,丁华锋,等.血清Copeptin、IGF-Ⅱ联合APACHE Ⅱ评分对颅脑外伤患者预后的预测价值[J].国际神经病学神经外科学杂志,2021,48(3):231-234.
[23] 谢元润,马迎辉,叶继业,等.血清和肽素、胰岛素样生长因子-Ⅱ联合急性生理和慢性健康评估系统Ⅱ评分对颅脑外伤患者预后的预测价值[J].心脑血管病防治,2021,21(4):411-414.
[24] 李艳,曹锋生,祝伟.和肽素和凝血功能监测在重型脑外伤病情评估和预后判断中的作用[J].内科急危重症杂志,2017,23(2):139-141,174.
[25] 陈锐,张高炼,黄建荣,等.血清HMGB1及Copeptin检测对脑外伤患者病情严重程度及预后评估临床意义[J].现代检验医学杂志,2018,33(3):38-43.

备注/Memo

备注/Memo:
[基金项目]山东省卫生健康委员会医学科学研究计划项目(2023FYR-3627)
更新日期/Last Update: 2025-02-04